Efficacy and Safety of Pramipexole Sustained Release versus Immediate Release Formulation for Nocturnal Symptoms in Chinese Patients with Advanced Parkinson’s Disease: A Pilot Study
Objective. To explore the efficacy and safety of pramipexole sustained release (SR) versus pramipexole immediate release (IR) in treating nocturnal symptoms in levodopa-treated Chinese patients with advanced Parkinson’s disease (PD) and sleep disturbances. Method. SUSTAIN was an open-label, randomis...
Main Authors: | Haiyan Zhou, Shuhua Li, Hongmei Yu, Shenggang Sun, Xinhua Wan, Xiaodong Zhu, Chun-Feng Liu, Ling Chen, Wei Xiang, Yaqing Sun, Haibo Chen, Shengdi Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.1155/2021/8834950 |
Similar Items
-
Comparison of nocturnal symptoms in advanced Parkinson’s disease patients with sleep disturbances: pramipexole sustained release versus immediate release formulations
by: Xiang W, et al.
Published: (2018-07-01) -
Pramipexole and its Extended Release Formulation for Parkinson’s Disease
by: Paul S. Fishman
Published: (2011-06-01) -
Pramipexole and its Extended Release Formulation for Parkinson's Disease
by: Paul S. Fishman
Published: (2011-01-01) -
Switch from Immediate-release Pramipexole to Extended-release Pramipexole: The Safety and Efficacy Characteristics of Sixty-eight Patients
by: Müge Kuzu, et al.
Published: (2016-09-01) -
The Feasibility of Overnight Switching of Pramipexole from Immediate-release to Extended-release Formulation in Early Parkinson''s Disease: An Open-labeled, Crossover Study in Taiwan
by: Chu-Yun Huang, et al.
Published: (2012)